Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale Director sold 10,000 shares at $34.63 ($346,300)
  2. 4 Open-market sale SVP & Chief Financial Officer sold 25,000 shares at $33.71 ($842,750)
  3. 4 Open-market sale President & CEO sold 100,000 shares at an average $33.00 ($3,300,000)
  4. 4 Open-market sale SVP & Chief Accounting Officer sold 1,928 shares at $31.37 ($60,481)
  5. 4 Open-market sale President & CEO sold 13,383 shares at $31.37 ($419,825)
  6. 4 Open-market sale SVP & Chief Operating Officer sold 4,077 shares at $31.37 ($127,895)
  7. 4 Open-market sale SVP & Chief Financial Officer sold 3,767 shares at $31.37 ($118,171)
  8. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,449 shares at $31.37 ($76,825)
  9. 4 Open-market sale SVP & Chief Scientific Officer sold 3,461 shares at $31.37 ($108,572)
  10. 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
  11. 4 Open-market sale SVP & Chief Accounting Officer sold 1,808 shares at $42.39 ($76,641)
  12. 4 Open-market sale President & CEO sold 108,882 shares at an average $42.19 ($4,594,176)
  13. 4 Open-market sale SVP & Chief Operating Officer sold 3,822 shares at $42.39 ($162,015)
  14. 4 Open-market sale SVP & Chief Financial Officer sold 3,592 shares at $42.39 ($152,265)
  15. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,386 shares at $42.39 ($101,143)
  16. 4 Open-market sale SVP & Chief Scientific Officer sold 3,310 shares at $42.39 ($140,311)
  17. 4 Open-market sale SVP & Chief Accounting Officer sold 16,119 shares at $42.16 ($679,577)
  18. 4 Open-market sale SVP & Chief Operating Officer sold 63,000 shares at $42.82 ($2,697,660)
  19. 4 Grant or award SVP & Chief Accounting Officer acquired 10,950 shares (grant or award)
  20. 4 Grant or award President & CEO acquired 68,450 shares (grant or award)

Page 15 of 49 · 970 filings